Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 3, 2017, Pages 485-494

  Li, Yang ^a   Liu, Yanxia ^a   Tian, Xiaoxiang ^a   Zhang, Yan ^a   Song, Haixu ^a   Liu, Meili ^a   Zhang, Xiaolin ^a   Liu, Haiwei ^a   Zhang, Jian ^a   Zhang, Quanyu ^a   Liu, Dan ^a   Peng, Chengfei ^a   Yan, Chenghui ^a   Han, Yaling ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Ang II; CREG; Ets1; vascular remodeling; VSMCs

Indexed keywords

ANGIOTENSIN II; CELLULAR REPRESSOR OF E1A STIMULATED GENE; GLYCOPROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS1; UNCLASSIFIED DRUG; CREG PROTEIN, MOUSE; CREG PROTEIN, RAT; CREG1 PROTEIN, HUMAN; ETS1 PROTEIN, MOUSE; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; SALT INTAKE; TRANSCRIPTION FACTOR ETS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DOWN REGULATION; GENE EXPRESSION REGULATION; GENOTYPE; HYPERTENSION; MESENTERIC ARTERY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; THORACIC AORTA; UPREGULATION; VASCULAR FIBROSIS; VASCULAR REMODELING; VASCULAR TISSUE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DAHL RAT; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENETIC TRANSFECTION; GENETICS; HYPERTROPHY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SALT INTAKE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; TIME FACTOR; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROSIS; HYPERTENSION; HYPERTROPHY; MESENTERIC ARTERIES; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEIN C-ETS-1; RATS, INBRED DAHL; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY; TIME FACTORS; TRANSFECTION; VASCULAR REMODELING;

EID: 85008324839     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.308794     Document Type: Article

References (30)

1. Holobotovskyy V, Manzur M, Tare M, Burchell J, Bolitho E, Viola H, Hool LC, Arnolda LF, McKitrick DJ, Ganss R, Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling. Circ Res 2013 112 781 791. doi: 10.1161/CIRCRESAHA.111.300142.
2. Intengan HD, Schiffrin EL, Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001 38 3 p t 2 581 587
3. Gibbons GH, Dzau VJ, The emerging concept of vascular remodeling. N Engl J Med 1994 330 1431 1438. doi: 10.1056/NEJM199405193302008.
4. Pacurari M, Kafoury R, Tchounwou PB, Ndebele K, The Renin-Angiotensin-Aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014 2014 689360. doi: 10.1155/2014/689360.
5. Patel VB, Zhong JC, Fan D, Basu R, Morton JS, Parajuli N, McMurtry MS, Davidge ST, Kassiri Z, Oudit GY, Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling. Hypertension 2014 64 157 164. doi: 10.1161/HYPERTENSIONAHA.114.03388.
6. Savoia C, Touyz RM, Volpe M, Schiffrin EL, Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007 49 341 346. doi: 10.1161/01.HYP.0000253968.95136.b8.
7. Kowalewski-Nimmerfall E, Schähs P, Maresch D, Rendic D, Krämer H, Mach L, Drosophila melanogaster cellular repressor of E1A-stimulated genes is a lysosomal protein essential for fly development. Biochim Biophys Acta 2014 1843 2900 2912. doi: 10.1016/j.bbamcr.2014.08.012.
8. Li Y, Yan CH, Li SH, Han YL, CREG: A possible candidate for both prevention and treatment of proliferative vascular disease. Curr Mol Med 2012 12 1273 1281
9. Veal E, Eisenstein M, Tseng ZH, Gill G, A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol Cell Biol 1998 18 5032 5041
10. Veal E, Groisman R, Eisenstein M, Gill G, The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene 2000 19 2120 2128. doi: 10.1038/sj.onc.1203529.
11. Yang G, Han Y, Tian X, Tao J, Sun M, Kang J, Yan C, Pattern of expression of the CREG gene and CREG protein in the mouse embryo. Mol Biol Rep 2011 38 2133 2140. doi: 10.1007/s11033-010-0340-7.
12. Han Y, Deng J, Guo L, Yan C, Liang M, Kang J, Liu H, Graham AM, Li S, CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc Res 2008 78 597 604. doi: 10.1093/cvr/cvn036.
13. Han Y, Luan B, Sun M, Guo L, Guo P, Tao J, Deng J, Wu G, Liu S, Yan C, Li S, Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells. J Mol Cell Cardiol 2011 50 723 730. doi: 10.1016/j.yjmcc.2010.12.013.
14. Han Y, Wu G, Deng J, Tao J, Guo L, Tian X, Kang J, Zhang X, Yan C, Cellular repressor of E1A-stimulated genes inhibits human vascular smooth muscle cell apoptosis via blocking P38/JNK MAP kinase activation. J Mol Cell Cardiol 2010 48 1225 1235. doi: 10.1016/j.yjmcc.2009.12.018.
15. Deng J, Han Y, Sun M, Tao J, Yan C, Kang J, Li S, Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries. PLoS One 2013 8 e60735. doi: 10.1371/journal.pone.0060735.
16. Han Y, Zhao X, Yan C, Kang J, Zhang X, Deng J, Xu H, Liu H, Transcriptional factor e2f1 inhibits expression of the cellular repressor of e1a-stimulated genes and regulates vsmcs differentiation in vitro. Prog Biochem Biophys 2007 34 490 496
17. Wang J, Yan CH, Li Y, Xu K, Tian XX, Peng CF, Tao J, Sun MY, Han YL, MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res 2013 319 1165 1175. doi: 10.1016/j.yexcr.2013.03.010.
18. Peng C, Pei H, Wei F, Tian X, Deng J, Yan C, Li Y, Sun M, Zhang J, Liu D, Rong J, Wang J, Gao E, Li S, Han Y, Cellular repressor of E1A-stimulated gene overexpression in bone mesenchymal stem cells protects against rat myocardial infarction. Int J Cardiol 2015 183 232 241. doi: 10.1016/j.ijcard.2015.01.059.
19. Li Y, Tao J, Zhang J, Tian X, Liu S, Sun M, Zhang X, Yan C, Han Y, Cellular repressor E1A-stimulated genes controls phenotypic switching of adventitial fibroblasts by blocking p38MAPK activation. Atherosclerosis 2012 225 304 314. doi: 10.1016/j.atherosclerosis.2012.08.015.
20. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P, Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005 115 2508 2516. doi: 10.1172/JCI24403.
21. Ni W, Zhan Y, He H, Maynard E, Balschi JA, Oettgen P, Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res 2007 101 985 994. doi: 10.1161/CIRCRESAHA.107.152439.
22. Lewis BP, Burge CB, Bartel DP, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 15 20. doi: 10.1016/j.cell.2004.12.035.
23. Testoni M, Chung EY, Priebe V, Bertoni F, The transcription factor ets1 in lymphomas: Friend or foe? Leuk Lymphoma 2014 1 15
24. Lo IC, Lin TM, Chou LH, Liu SL, Wu LW, Shi GY, Wu HL, Jiang MJ, Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells. Cardiovasc Res 2009 81 771 779. doi: 10.1093/cvr/cvn351.
25. Feng W, Chumley P, Hua P, Rezonzew G, Jaimes D, Duckworth MW, Xing D, Jaimes EA, Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II. Hypertension 2012 60 1226 1233. doi: 10.1161/HYPERTENSIONAHA.112.197871.
26. Katsume A, Okigaki M, Matsui A, Che J, Adachi Y, Kishita E, Yamaguchi S, Ikeda K, Ueyama T, Matoba S, Yamada H, Matsubara H, Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-Alpha and subsequent activation of the p21Cip1/Ets-1/p300 system. Arterioscler Thromb Vasc Biol 2011 31 1084 1092. doi: 10.1161/ATVBAHA.110.221804.
27. Feng W, Chumley P, Prieto MC, Miyada K, Seth DM, Fatima H, Hua P, Rezonzew G, Sanders PW, Jaimes EA, Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension. Hypertension 2015 65 813 820. doi: 10.1161/HYPERTENSIONAHA.114.04533.
28. Lee CG, Kwon HK, Sahoo A, Hwang W, So JS, Hwang JS, Chae CS, Kim GC, Kim JE, So HS, Hwang ES, Grenningloh R, Ho IC, Im SH, Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells. J Immunol 2012 188 2244 2253. doi: 10.4049/jimmunol.1101614.
29. Meng FK, Sun HY, Tan XY, Li CR, Zhou JF, Liu WL, Negative regulation of cyclin D3 expression by transcription factor c-Ets1 in umbilical cord hematopoietic cells. Acta Pharmacol Sin 2011 32 1159 1164. doi: 10.1038/aps.2011.41.
30. Hahne JC, Okuducu AF, Fuchs T, Florin A, Wernert N, Identification of ETS-1 target genes in human fibroblasts. Int J Oncol 2011 38 1645 1652. doi: 10.3892/ijo.2011.981.